How Do Cannabis and Synthetic Cannabinoids Affect Neurocognitive Functions

dc.contributor.author Hande Celikay Soyler
dc.contributor.author Ayse Ender Altintoprak
dc.contributor.author Ebru Ozturk Aldemir
dc.date WIN
dc.date.accessioned 2025-10-06T16:22:17Z
dc.date.issued 2022
dc.description.abstract Objective: In this study the losses of neurocognitive function caused by the use of cannabis and synthetic cannabinoids were studied on specific cognitive areas (attention and working memory executive functions visuospatial perception learning and memory planning and problem solving word naming) and were described in comparison with healthy controls (control group). Method: In this study while 52 participants who applied to Ege University Faculty of Medicine Department of Mental Health and Mental Disorders Drug Addiction Treatment Center Clinic between March 2015 - February 2017 and used cannabis at least for one year in the past and 51 participants who used synthetic cannabinoids for at least one year in the past were participant groups with a history of substance use, 57 staff/student of Ege University with no history of any substance use were participants of the control group. The research sample consisted of 160 participants. The sample group consisted of 160 men aged 18-35 and also 16 participants aged 36-54 were involved in the study in order to observe neuropsychological functions that changed with age. Stroop Test for attention area Raven Standart Progressive Matrices Test for executive functions area Line Orientation Test and Cancellation Test for visuospatial perception area Serial Digit Learning Test and Oktem Verbal Memory Progresses Scale for learning and memory area The Tower of London Test for planning and problem solving skill Boston Naming Test for word naming area were used. Results: In this study while the lowest perfomance on the ability of focused attention visuospatial cognition visual scanning orientation sustained attention general ability short-term memory learning long-term memory word naming was shown by the participants with a history of synthetic cannabis use the participants with a history of cannabis use had the lowest performance on the ability of response rate perseveration conceptualizing abstract thinking changing sets recognition. Participants' history of substance use did not affect the ability of planning and problem solving. Conclusion: In conclusion this study suggests that the addition of cognitive rehabilitation programs to medical and psychosocial improvement studies carried out in the field of addiction will increase the success.
dc.identifier.doi 10.5080/u26956
dc.identifier.issn 1300-2163
dc.identifier.uri http://dx.doi.org/10.5080/u26956
dc.identifier.uri https://gcris.yasar.edu.tr/handle/123456789/7316
dc.language.iso English
dc.publisher TURKIYE SINIR VE RUH SAGLIGI DERNEGI
dc.relation.ispartof Turkish Journal of Psychiatry
dc.source TURK PSIKIYATRI DERGISI
dc.subject Neurocognitive function, cannabis cynthetic cannabinoid
dc.subject NEUROPSYCHOLOGICAL PERFORMANCE, MARIJUANA, USERS, ALCOHOL, COGNITION, DEFICITS, FAMILY, IMPACT, SAMPLE, MEMORY
dc.title How Do Cannabis and Synthetic Cannabinoids Affect Neurocognitive Functions
dc.type Article
dspace.entity.type Publication
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.identifier.openalex W4312583578
gdc.identifier.pmid 36592102
gdc.index.type WoS
gdc.oaire.accesstype GOLD
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.3811355E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Male
gdc.oaire.keywords Executive Function
gdc.oaire.keywords Cognition
gdc.oaire.keywords Cannabinoids
gdc.oaire.keywords Substance-Related Disorders
gdc.oaire.keywords Humans
gdc.oaire.keywords Neuropsychological Tests
gdc.oaire.keywords Cannabis
gdc.oaire.popularity 1.6828513E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.openalex.fwci 0.3483
gdc.openalex.normalizedpercentile 0.64
gdc.opencitations.count 0
gdc.plumx.mendeley 23
gdc.plumx.newscount 2
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 0
oaire.citation.endPage 247
oaire.citation.startPage 233
publicationissue.issueNumber 4
publicationvolume.volumeNumber 33
relation.isOrgUnitOfPublication ac5ddece-c76d-476d-ab30-e4d3029dee37
relation.isOrgUnitOfPublication.latestForDiscovery ac5ddece-c76d-476d-ab30-e4d3029dee37

Files

Original bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
tpd_c33_s4_233-247.pdf
Size:
248.59 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
10.35378-gujs.770814-1206330.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format